Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pomalidomide for Chronic GvHD
NCT01688466Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Aug 2012
- Primary completion
- Mar 2017
- Modality
- Molecular Glues
- Countries
- 1
01
Overview
A Phase 2 trial of pomalidomide in chronic graft-versus-host disease (cGVHD), sponsored by National Cancer Institute. Started Aug 2012; status: completed.
02
Drugs
pomalidomide
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT01688466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01688466.